Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a Phase 2, randomized, placebo-controlled study.

Rheumatology (Oxford, England)
2024
https://researcherprofiles.org/profile/570244384
39673415
Anders HJ, Chan TM, Sanchez-Guerrero J, Wofsy D, Bensley K, Kim L, Hung Lo K, Shu C, Shao J, Karyekar CS, Diamond B